Guidance

Bisphosphonates: use and safety

Guidance on the use and safety of bisphosphonates for bone-related conditions.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 18 December 2014

Documents

Bisphosphonates: use and safety

HTML

Details

This Medicines and Healthcare Products Regulatory Agency (MHRA) guidance for healthcare professionals covers:

• oesophageal reactions
• osteonecrosis of the jaw
• atrial fibrillation
• atypical femoral fractures
• adverse effects on renal function

Published 18 December 2014